The interferon renaissance: molecular aspects of induction and action

Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand.

Blood·1998

Measuring the hospital experiences of junior doctors.

Medical education·1998

A system for maintaining the educational and training standards of junior doctors.

Medical education·1998

In vivo validation of tissue segmentation based on a 3D feature map using both a hamster brain tumor model and stereotactically guided biopsy of brain tumors in man.

Journal of magnetic resonance imaging : JMRI·1998

Release of clonal block in B cell chronic lymphocytic leukaemia by engagement of co-operative epitopes on CD40.

Leukemia research·1998

Tumor pathogenesis of human neurotropic JC virus in the CNS.

Journal of neurovirology·1998

T helper cell activation and human retroviral pathogenesis.

Microbiological reviews·1996

The secretory pathway of protists: spatial and functional organization and evolution.

Microbiological reviews·1996

Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses.

Microbiological reviews·1996

Soil microorganisms as controllers of atmospheric trace gases (H2, CO, CH4, OCS, N2O, and NO).

Microbiological reviews·1996

Proton-dependent multidrug efflux systems.

Microbiological reviews·1996

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Microbiological reviews·1996

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

British journal of haematology·2026

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

ACR open rheumatology·2026

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

BMC neurology·2026

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Advances in immunology·2026

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Lancet (London, England)·2026

Expanding the therapeutic landscape of Still's disease: the emerging role of JAK inhibitors.

Expert opinion on pharmacotherapy·2026

Related Experiment Videos

The interferon renaissance: molecular aspects of induction and action

Related Concept Videos

Prolonged phenotypic, functional, and molecular change in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand.

Measuring the hospital experiences of junior doctors.

A system for maintaining the educational and training standards of junior doctors.

In vivo validation of tissue segmentation based on a 3D feature map using both a hamster brain tumor model and stereotactically guided biopsy of brain tumors in man.

Release of clonal block in B cell chronic lymphocytic leukaemia by engagement of co-operative epitopes on CD40.

Tumor pathogenesis of human neurotropic JC virus in the CNS.

T helper cell activation and human retroviral pathogenesis.

The secretory pathway of protists: spatial and functional organization and evolution.

Flow cytometry and cell sorting of heterogeneous microbial populations: the importance of single-cell analyses.

Soil microorganisms as controllers of atmospheric trace gases (H2, CO, CH4, OCS, N2O, and NO).

Proton-dependent multidrug efflux systems.

Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia.

Increased anergic B cells and decreased antibody-secreting cells during romiplostim treatment in patients with immune thrombocytopenia.

Passive Transfer of Hepatitis B Core Antibody Following Intravenous Ig Administration: Clinical Implications and Considerations.

Investigating the role of serum IL-6 in predicting outcomes of b-cell depleting therapy in multiple sclerosis: a retrospective cohort study.

iPSC-derived neurospheres: A cellular platform for Tau and Alzheimer's disease immunotherapy.

Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study.

Expanding the therapeutic landscape of Still's disease: the emerging role of JAK inhibitors.

Related Experiment Videos

The interferon renaissance: molecular aspects of induction and action

Related Concept Videos

Related Articles